Jazz Pharmaceuticals
JAZZ
#2156
Rank
C$10.06 B
Marketcap
$166.55
Share price
2.07%
Change (1 day)
0.59%
Change (1 year)

Earnings for Jazz Pharmaceuticals (JAZZ)

Earnings in 2024 (TTM): C$0.40 Billion

According to Jazz Pharmaceuticals's latest financial reports the company's current earnings are C$3.90 Billion. In 2023 the company made an earning of C$0.41 Billion, an increase over its 2022 earnings that were of -C$0.53 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Jazz Pharmaceuticals from 2005 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) C$0.40 B-3.02%
2023 C$0.41 B-179.92%
2022 -C$0.53 Billion230.37%
2021 -C$0.16 Billion-141.02%
2020 C$0.38 B-39.45%
2019 C$0.63 B-14.2%
2018 C$0.73 B20.03%
2017 C$0.61 B-17.15%
2016 C$0.74 B22.14%
2015 C$0.60 B187.64%
2014 C$0.21 B-50.79%
2013 C$0.43 B73.63%
2012 C$0.24 B41.69%
2011 C$0.17 B116.61%
2010 C$80.71 M262.77%
2009 C$22.25 M-111.33%
2008 -C$0.2 Billion1.31%
2007 -C$0.2 Billion77.8%
2006 -C$0.11 Billion36.59%
2005 -C$79.82 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-C$3.35 Billion-904.36%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
C$2.92 B 605.10%๐Ÿ‡บ๐Ÿ‡ธ USA
C$17.78 B 4,181.55%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
C$1.15 B 178.11%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel